Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q10472

Entry ID Method Resolution Chain Position Source
AF-Q10472-F1 Predicted AlphaFoldDB

312 variants for Q10472

Variant ID(s) Position Change Description Diseaes Association Provenance
rs766763738
CA8937990
4 F>L No ClinGen
ExAC
gnomAD
CA402287134
rs1464564617
4 F>S No ClinGen
TOPMed
gnomAD
CA402287137
rs778731854
5 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA8937991
rs778731854
5 A>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 9 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 12 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1428595362
CA402287194
13 T>I No ClinGen
gnomAD
rs1428595362
CA402287192
13 T>N No ClinGen
gnomAD
rs1555647689
CA402287211
16 I>S No ClinGen
Ensembl
rs141224997
CA8937995
20 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8937997
rs138822379
25 L>V No ClinGen
ESP
ExAC
rs770545931
CA8937998
27 Y>F No ClinGen
ExAC
gnomAD
rs1358054040
CA402287298
29 S>G No ClinGen
TOPMed
gnomAD
CA402287302
rs1386465656
29 S>I No ClinGen
gnomAD
CA298643641
rs1007063660
30 E>A No ClinGen
TOPMed
CA402287311
rs1384609242
30 E>D No ClinGen
gnomAD
rs745689841
CA8938000
33 K>R No ClinGen
ExAC
gnomAD
rs999525441
CA298643642
34 C>R No ClinGen
Ensembl
CA8938001
rs769729231
36 E>G No ClinGen
ExAC
gnomAD
CA402287358
rs1328935980
37 K>E No ClinGen
gnomAD
CA8938002
rs775428732
38 K>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1225897793 38 K>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1012535388
CA298643644
39 E>K No ClinGen
Ensembl
CA402287393
rs1325881273
42 L>I No ClinGen
TOPMed
TCGA novel 44 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs898156871
CA298643645
45 G>* No ClinGen
TOPMed
gnomAD
rs993826075
CA298643646
45 G>V No ClinGen
TOPMed
gnomAD
CA8938005
rs199595808
46 D>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs772144264
CA8938004
46 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs760876380
CA8938007
47 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1182627562
CA402287993
48 L>V No ClinGen
gnomAD
rs1385293058
CA402288008
50 P>L No ClinGen
gnomAD
rs771147576
CA8938028
51 V>A No ClinGen
ExAC
gnomAD
rs572266534
CA8938027
51 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs572266534
CA8938026
51 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8938029
rs367800500
52 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8938030
rs72964406
54 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1300195566
CA402288038
55 H>L No ClinGen
gnomAD
rs1377477734
CA402288049
56 E>D No ClinGen
gnomAD
CA402288052
rs1452129148
57 G>C No ClinGen
gnomAD
TCGA novel 60 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8938032
rs753167333
61 M>R No ClinGen
ExAC
TOPMed
gnomAD
rs746621854
CA402288102
64 P>L No ClinGen
TOPMed
gnomAD
rs746621854
CA298644557
64 P>R No ClinGen
TOPMed
gnomAD
rs1252809222
CA402288119
66 V>A No ClinGen
gnomAD
CA402288112
rs1205136450
66 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1482183016
CA402288123
67 I>F No ClinGen
gnomAD
CA8938036
rs751072237
68 P>L No ClinGen
ExAC
gnomAD
CA8938035
rs751072237
68 P>R No ClinGen
ExAC
gnomAD
rs1243451516
CA402288151
70 E>K No ClinGen
gnomAD
rs139185162
CA8938038
71 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8938037
rs150799030
71 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA402288193
rs1245209846
75 M>T No ClinGen
Ensembl
CA8938041
rs749132119
79 F>L No ClinGen
ExAC
TCGA novel 81 I>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1239143002
CA402288249
82 N>S No ClinGen
TOPMed
CA402288285
rs1429588681
87 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 91 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754881258
CA8938042
92 I>N No ClinGen
ExAC
gnomAD
CA402288330
rs1469645315
93 A>T No ClinGen
gnomAD
CA298644560
rs933351911
99 P>L No ClinGen
Ensembl
CA8938045
rs770934329
102 R>K No ClinGen
ExAC
gnomAD
CA402288390
rs1568027118
102 R>W No ClinGen
Ensembl
rs746061435
CA8938047
105 G>V No ClinGen
ExAC
CA298645980
rs867040527
108 T>K No ClinGen
Ensembl
CA8938069
rs770099332
110 V>L No ClinGen
ExAC
gnomAD
CA8938070
rs775875852
111 Y>C No ClinGen
ExAC
gnomAD
TCGA novel 112 P>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749605460
CA8938071
116 P>R No ClinGen
ExAC
gnomAD
CA298645981
rs774063067
117 T>K No ClinGen
Ensembl
rs1326785769
CA402283764
118 T>A No ClinGen
TOPMed
rs1461013463
CA402283802
124 F>V No ClinGen
TOPMed
rs1172456216
CA402283823
126 N>K No ClinGen
TOPMed
rs769146513
CA8938073
126 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs762214145
CA8938075
131 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA298645982
rs1048020433
131 T>I No ClinGen
TOPMed
CA8938076
rs768119495
134 R>* No ClinGen
ExAC
gnomAD
CA8938077
rs561709986
134 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA402283894
rs1568030550
138 S>G No ClinGen
Ensembl
rs753504984
CA8938080
141 N>S No ClinGen
ExAC
gnomAD
rs765970495
CA8938079
141 N>Y No ClinGen
ExAC
gnomAD
rs754705600
CA8938081
COSM185365
142 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA298645983
rs113616262
143 S>P No ClinGen
Ensembl
rs764923250
CA8938082
144 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1417540136
CA402283943
146 H>D No ClinGen
TOPMed
gnomAD
rs777794360
CA8938085
147 M>I No ClinGen
ExAC
gnomAD
rs375594755
CA8938084
147 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 151 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402283987
rs1226694575
152 V>I No ClinGen
TOPMed
CA402283997
rs1381154447
153 L>R No ClinGen
gnomAD
rs1030435809
CA298645985
159 E>* No ClinGen
Ensembl
CA8938086
rs750418950
160 R>K No ClinGen
ExAC
gnomAD
rs375568312
CA8938106
165 R>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 168 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8938107
rs754020126
168 E>K No ClinGen
ExAC
gnomAD
rs1411488967
CA402284121
169 S>T No ClinGen
gnomAD
CA8938109
rs779228924
171 V>A No ClinGen
ExAC
gnomAD
CA8938110
rs748418527
175 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs772487798
CA8938111
177 P>Q No ClinGen
ExAC
gnomAD
CA402284261
rs1389318843
181 I>V No ClinGen
gnomAD
CA402284276
rs778080822
182 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs778080822
CA8938112
182 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8938113
rs747497904
186 R>C No ClinGen
ExAC
gnomAD
rs771471816
CA8938114
186 R>H No ClinGen
ExAC
gnomAD
rs769293373
CA8938117
197 A>V No ClinGen
ExAC
gnomAD
rs1205844059
CA402284493
198 A>V No ClinGen
gnomAD
rs775214348
TCGA novel
CA8938118
199 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
gnomAD
NCI-TCGA
TCGA novel 200 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1362204975
CA402284519
201 K>E No ClinGen
Ensembl
CA8938120
rs779097791
201 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs1170426593
CA402284537
202 G>D No ClinGen
TOPMed
CA298646520
rs1056636354
202 G>S No ClinGen
TOPMed
rs368652074
CA402284590
206 T>I No ClinGen
ESP
CA298646521
rs368652074
206 T>S No ClinGen
ESP
rs1464331042
CA402284616
208 L>P No ClinGen
TOPMed
CA8938121
rs751467082
209 D>Y No ClinGen
ExAC
gnomAD
CA8938122
rs201338228
216 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8938124
rs753918792
217 G>R No ClinGen
ExAC
TCGA novel 218 W>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1598805099
CA402284760
219 L>R No ClinGen
Ensembl
rs755114870
CA8938125
220 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA8938126
rs765307784
222 L>V No ClinGen
ExAC
gnomAD
CA8938128
rs758603020
225 R>G No ClinGen
ExAC
gnomAD
CA402284814
rs747427766
228 H>D No ClinGen
ExAC
TOPMed
gnomAD
rs1403639618
CA402284816
228 H>R No ClinGen
gnomAD
CA8938130
rs747427766
228 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA298646522
rs757716755
229 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1324739644
CA402284827
230 R>G No ClinGen
gnomAD
CA402284854
rs1346507106
232 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1407213480
CA402284856
232 T>K No ClinGen
TOPMed
gnomAD
rs1407213480
CA402284858
232 T>R No ClinGen
TOPMed
gnomAD
rs1300287293
CA402284893
238 I>V No ClinGen
TOPMed
CA8938145
rs765343176
239 D>N No ClinGen
ExAC
gnomAD
CA402284906
rs1357434996
240 V>M No ClinGen
gnomAD
rs1220123367
CA402284920
242 S>C No ClinGen
gnomAD
CA402284919
rs1220123367
242 S>G No ClinGen
gnomAD
rs1192109861
CA402284955
246 F>L No ClinGen
gnomAD
CA402284973
rs1424968700
249 M>L No ClinGen
gnomAD
rs752783575
CA8938146
254 M>T No ClinGen
ExAC
gnomAD
rs1490449464
CA402285026
256 Y>C No ClinGen
TOPMed
gnomAD
rs1490449464
CA402285027
256 Y>F No ClinGen
TOPMed
gnomAD
rs199977475
CA298646911
258 G>V No ClinGen
1000Genomes
CA402285041
rs1598806205
259 F>V No ClinGen
Ensembl
rs1598806206
CA402285080
264 N>H No ClinGen
Ensembl
CA298646912
rs1054039963
264 N>S No ClinGen
TOPMed
gnomAD
rs1054039963
CA402285083
264 N>T No ClinGen
TOPMed
gnomAD
rs758610887
CA8938147
266 R>H No ClinGen
ExAC
gnomAD
TCGA novel 267 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402285101
rs1418105232
267 W>R No ClinGen
gnomAD
CA402285110
rs1598806210
268 Y>D No ClinGen
Ensembl
CA8938148
rs764325416
269 P>R No ClinGen
ExAC
gnomAD
CA919963806
rs1598806213
270 V>D No ClinGen
Ensembl
rs751884824
CA8938149
271 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs757625159
CA8938150
272 Q>K No ClinGen
ExAC
gnomAD
TCGA novel 275 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781622310
CA8938151
275 M>V No ClinGen
ExAC
gnomAD
CA8938152
rs746375129
276 D>G No ClinGen
ExAC
gnomAD
rs1178955604
CA402285171
277 R>G No ClinGen
TOPMed
gnomAD
rs914531943
CA298646915
277 R>K No ClinGen
TOPMed
CA8938153
rs756647432
279 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs779585715
CA8938154
282 R>Q No ClinGen
ExAC
gnomAD
CA8938155
rs748798401
283 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA402285443
rs1305715324
288 T>A No ClinGen
gnomAD
rs1259767194
CA402285486
294 G>D No ClinGen
gnomAD
CA8938170
rs767865044
297 S>* No ClinGen
ExAC
gnomAD
rs1202667951 297 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs756622861
CA8938172
298 I>V No ClinGen
ExAC
gnomAD
rs1304313674
CA402285518
299 D>E No ClinGen
TOPMed
CA402285515
rs1471184782
299 D>G No ClinGen
Ensembl
CA298647116
rs567254339
299 D>N No ClinGen
gnomAD
CA402285519
rs1568033120
300 R>G No ClinGen
Ensembl
CA402285571
rs1173192365
306 I>M No ClinGen
gnomAD
CA8938173
rs780447412
306 I>T No ClinGen
ExAC
gnomAD
TCGA novel 308 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402285622
rs1170941065
314 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA402285642
rs1177479611
316 W>* No ClinGen
gnomAD
CA402285639
rs1212120054
316 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA402285665
rs920470976
320 N>H No ClinGen
TOPMed
rs920470976
CA298647117
320 N>Y No ClinGen
TOPMed
CA298647118
rs752038593
321 L>V No ClinGen
Ensembl
CA8938178
rs771914557
324 S>Y No ClinGen
ExAC
CA402285706
rs1428801233
326 R>K No ClinGen
gnomAD
rs1369205172
CA402285788
329 Q>H No ClinGen
gnomAD
TCGA novel 329 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1221748902
CA402285811
331 G>E No ClinGen
gnomAD
rs754313464
CA8938197
332 G>R No ClinGen
ExAC
gnomAD
rs1353856605
CA402285835
333 T>N No ClinGen
gnomAD
rs1265026869
CA402285888
337 V>I No ClinGen
TOPMed
rs1272971208
CA402286026
347 R>Q No ClinGen
TOPMed
rs1468759653
CA402286024
347 R>W No ClinGen
gnomAD
CA298647299
rs752126521
351 P>L No ClinGen
TOPMed
CA298647301
rs756025596
353 T>M No ClinGen
TOPMed
gnomAD
CA298647300
rs377522973
353 T>S No ClinGen
gnomAD
rs758097611
CA8938201
357 G>V No ClinGen
ExAC
gnomAD
rs777326059
CA8938202
358 T>I No ClinGen
ExAC
gnomAD
CA8938204
rs770648350
360 Q>H No ClinGen
ExAC
gnomAD
CA402286201
rs1336892539
361 I>V No ClinGen
TOPMed
rs745803826
CA8938206
368 R>* No ClinGen
ExAC
TOPMed
gnomAD
rs921371695
CA298647304
372 V>A No ClinGen
TOPMed
CA402286356
rs1171284997
372 V>M No ClinGen
TOPMed
CA402286380
rs1376983118
374 M>I No ClinGen
gnomAD
TCGA novel 374 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1178276678
CA402286391
376 E>* No ClinGen
TOPMed
rs866242826
CA298647305
378 K>N No ClinGen
Ensembl
rs144282744
CA298647306
379 N>H No ClinGen
ESP
gnomAD
CA8938208
rs774392647
379 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA402286424
rs1359267109
380 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs777562587
COSM1611206
CA298647307
382 Y>C liver [Cosmic] No ClinGen
cosmic curated
Ensembl
rs749317275
CA298647308
383 I>V No ClinGen
TOPMed
rs146565032
CA298647310
384 I>V No ClinGen
ESP
TOPMed
CA402286456
rs1292406147
385 S>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA402286494
rs1173873090
389 T>I No ClinGen
gnomAD
rs1037853133
CA298647411
390 K>E No ClinGen
gnomAD
rs759998430
CA8938237
395 D>A No ClinGen
ExAC
gnomAD
rs759998430
CA8938238
395 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs776158114
CA8938239
396 I>T No ClinGen
ExAC
gnomAD
COSM1611207
CA402286537
rs1335638591
396 I>V liver [Cosmic] No ClinGen
cosmic curated
gnomAD
CA402286547
rs1430687191
397 S>L No ClinGen
TOPMed
gnomAD
rs763511120
CA8938241
400 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs142387342
CA298647412
401 G>D No ClinGen
ESP
TOPMed
rs142387342
CA298647413
401 G>V No ClinGen
ESP
TOPMed
rs1202187282
CA402286623
409 K>R No ClinGen
gnomAD
rs1202187282
CA402286622
409 K>T No ClinGen
gnomAD
CA402286631
rs1445171030
410 P>L No ClinGen
gnomAD
CA8938245
rs750180079
410 P>S No ClinGen
ExAC
gnomAD
CA402286627
rs750180079
410 P>T No ClinGen
ExAC
gnomAD
rs755906540
CA8938246
412 S>F No ClinGen
ExAC
gnomAD
CA402286648
rs1263600061
413 W>* No ClinGen
gnomAD
VAR_033946
rs34304568
CA298647414
414 Y>D No ClinGen
UniProt
Ensembl
dbSNP
CA8938247
rs779908232
418 I>M No ClinGen
ExAC
rs1598808149
CA402286689
419 Y>H No ClinGen
Ensembl
CA8938248
rs749207892
420 P>L No ClinGen
ExAC
gnomAD
rs749207892
CA8938249
420 P>R No ClinGen
ExAC
gnomAD
CA402286698
rs1284869425
420 P>S No ClinGen
TOPMed
rs913416555
CA298647416
423 Q>* No ClinGen
TOPMed
gnomAD
CA8938250
rs777681123
426 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA8938251
rs747158950
426 R>H No ClinGen
ExAC
gnomAD
rs996376176
CA298647417
428 Y>C No ClinGen
Ensembl
CA402286755
rs1284345940
429 F>V No ClinGen
TOPMed
CA402287439
rs1598812728
434 I>T No ClinGen
Ensembl
CA402287443
rs749687300
435 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs749687300
CA402287442
435 R>G No ClinGen
ExAC
gnomAD
rs769004825
CA8938287
435 R>Q No ClinGen
ExAC
gnomAD
rs774927948
CA8938288
437 V>M No ClinGen
ExAC
gnomAD
rs1443269571
CA402287459
438 E>K No ClinGen
gnomAD
rs368664035
CA8938289
439 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs771557387
CA8938290
440 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA402287484
rs1253941596
441 Q>R No ClinGen
TOPMed
CA402287527
rs1166531397
447 A>S No ClinGen
gnomAD
rs1399747847
CA402287533
448 R>K No ClinGen
gnomAD
CA402287542
rs1487556097
449 K>R No ClinGen
TOPMed
CA402287546
rs1333394500
450 E>K No ClinGen
gnomAD
CA402287578
rs1234609418
454 V>I No ClinGen
TOPMed
rs1450321228
CA402287604
457 F>L No ClinGen
TOPMed
gnomAD
rs766066560
CA8938293
461 G>S No ClinGen
ExAC
gnomAD
CA8938294
rs753525629
462 M>I No ClinGen
ExAC
rs1322092034
CA402287645
463 G>E No ClinGen
gnomAD
TCGA novel 467 V>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1256109086
CA402287700
469 S>C No ClinGen
TOPMed
gnomAD
CA402287701
rs1256109086
469 S>F No ClinGen
TOPMed
gnomAD
CA402287696
rs1208737210
469 S>T No ClinGen
gnomAD
rs1484498272
CA402287707
470 Y>F No ClinGen
gnomAD
CA8938321
rs542498158
476 I>L No ClinGen
1000Genomes
ExAC
gnomAD
COSM988169
rs1478393252
CA402287761
478 T>A Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA402287779
rs77648082
480 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8938324
rs775191976
483 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs1159418914
CA402287831
488 L>F No ClinGen
Ensembl
CA402287851
rs1360988624
491 P>S No ClinGen
gnomAD
rs750493267
CA8938327
494 M>I No ClinGen
ExAC
gnomAD
CA402287868
rs764151758
494 M>L No ClinGen
ExAC
gnomAD
CA8938326
rs764151758
494 M>V No ClinGen
ExAC
gnomAD
rs969413269
CA298648557
495 L>P No ClinGen
TOPMed
CA8938328
rs756266958
495 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA8938329
rs766455856
496 K>Q No ClinGen
ExAC
gnomAD
rs1183420751
CA402287903
499 H>Y No ClinGen
TOPMed
CA402287912
rs1437892921
500 L>P No ClinGen
TOPMed
TCGA novel 502 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8938334
rs758850679
509 D>N No ClinGen
ExAC
gnomAD
TCGA novel 510 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8938335
rs142110831
510 P>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 511 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761898143
CA8938345
512 K>T No ClinGen
ExAC
gnomAD
CA402288472
rs1384871399
518 V>M No ClinGen
TOPMed
CA402288488
rs1479788047
520 S>G No ClinGen
gnomAD
rs1178056201
CA402288494
521 N>H No ClinGen
gnomAD
CA298649206
rs1043866699
522 Q>* No ClinGen
TOPMed
CA8938349
rs765397647
525 D>H No ClinGen
ExAC
gnomAD
CA8938350
rs753015889
528 T>A No ClinGen
ExAC
gnomAD
rs758764811
CA8938351
530 E>K No ClinGen
ExAC
gnomAD
CA402288582
rs1404615329
533 Q>R No ClinGen
gnomAD
rs374506211
CA8938352
536 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs747514160
CA8938353
536 S>T No ClinGen
ExAC
gnomAD
CA402288606
rs1294756073
537 I>V No ClinGen
TOPMed
CA402288620
rs1330028079
539 D>H No ClinGen
gnomAD
rs1052733833
CA298649208
541 N>H No ClinGen
TOPMed
rs145884536
CA8938354
541 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8938356
rs745396196
544 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1711207
CA8938355
rs780735905
544 R>W Variant assessed as Somatic; 0.0 impact. skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs769448235
CA8938357
545 S>T No ClinGen
ExAC
gnomAD
TCGA novel 547 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 549 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8938358
rs779578114
549 L>V No ClinGen
ExAC
gnomAD
CA402288695
rs1598815852
550 L>F No ClinGen
Ensembl
CA402288700
rs1598815854
551 R>* No ClinGen
Ensembl
CA8938359
rs368892040
551 R>Q Variant assessed as Somatic; 4.621e-05 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8938361
rs768559745
CA402288709
552 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA8938362
rs200444543
553 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA402288725
rs1183890361
555 L>P No ClinGen
gnomAD
rs1459200345
CA402288722
555 L>V No ClinGen
gnomAD
rs776723493
CA8938364
556 P>R No ClinGen
ExAC
gnomAD
CA298649209
rs891889403
559 F>L No ClinGen
Ensembl
TCGA novel 559 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with Q10472

3 regional properties for Q10472

Type Name Position InterPro Accession
domain Ricin B, lectin domain 426 - 551 IPR000772
domain Glycosyltransferase 2-like 119 - 303 IPR001173
domain N-acetylgalactosaminyltransferase 119 - 419 IPR045885

Functions

Description
EC Number 2.4.1.41 Hexosyltransferases
Subcellular Localization
  • [Polypeptide N-acetylgalactosaminyltransferase 1]: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
endoplasmic reticulum-Golgi intermediate compartment membrane The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
Golgi cisterna membrane The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.

3 GO annotations of molecular function

Name Definition
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
manganese ion binding Binding to a manganese ion (Mn).
polypeptide N-acetylgalactosaminyltransferase activity Catalysis of the reaction: UDP-N-acetyl-D-galactosamine + polypeptide = UDP + N-acetyl-D-galactosaminyl-polypeptide. This reaction is the modification of serine or threonine residues in polypeptide chains by the transfer of a N-acetylgalactose from UDP-N-acetylgalactose to the hydroxyl group of the amino acid; it is the first step in O-glycan biosynthesis.

5 GO annotations of biological process

Name Definition
O-glycan processing The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.
protein O-linked glycosylation A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of peptidyl-serine, peptidyl-threonine, peptidyl-hydroxylysine, or peptidyl-hydroxyproline, or via the phenol group of peptidyl-tyrosine, forming an O-glycan.
protein O-linked glycosylation via serine The glycosylation of protein via the O3 atom of peptidyl-serine, forming O3-glycosyl-L-serine; the most common forms are N-acetylgalactosaminyl, mannosyl, galactosyl, and xylosyl serine.
protein O-linked glycosylation via threonine The glycosylation of protein via the O3 atom of peptidyl-threonine, forming O3-glycosyl-L-threonine; the most common forms are N-acetylgalactosaminyl, mannosyl, and galactosyl threonine.
viral protein processing Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.

26 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q07537 GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 Bos taurus (Bovine) PR
Q6WV16 Pgant6 N-acetylgalactosaminyltransferase 6 Drosophila melanogaster (Fruit fly) PR
Q6WV17 Pgant5 Polypeptide N-acetylgalactosaminyltransferase 5 Drosophila melanogaster (Fruit fly) PR
Q9Y117 Pgant3 Polypeptide N-acetylgalactosaminyltransferase 3 Drosophila melanogaster (Fruit fly) PR
Q14435 GALNT3 Polypeptide N-acetylgalactosaminyltransferase 3 Homo sapiens (Human) PR
Q49A17 GALNTL6 Polypeptide N-acetylgalactosaminyltransferase-like 6 Homo sapiens (Human) PR
Q7Z7M9 GALNT5 Polypeptide N-acetylgalactosaminyltransferase 5 Homo sapiens (Human) PR
Q86SR1 GALNT10 Polypeptide N-acetylgalactosaminyltransferase 10 Homo sapiens (Human) PR
Q8IUC8 GALNT13 Polypeptide N-acetylgalactosaminyltransferase 13 Homo sapiens (Human) PR
Q8IXK2 GALNT12 Polypeptide N-acetylgalactosaminyltransferase 12 Homo sapiens (Human) PR
Q9NY28 GALNT8 Probable polypeptide N-acetylgalactosaminyltransferase 8 Homo sapiens (Human) PR
Q86SF2 GALNT7 N-acetylgalactosaminyltransferase 7 Homo sapiens (Human) PR
Q10471 GALNT2 Polypeptide N-acetylgalactosaminyltransferase 2 Homo sapiens (Human) PR
Q96FL9 GALNT14 Polypeptide N-acetylgalactosaminyltransferase 14 Homo sapiens (Human) PR
P70419 Galnt3 Polypeptide N-acetylgalactosaminyltransferase 3 Mus musculus (Mouse) PR
Q921L8 Galnt11 Polypeptide N-acetylgalactosaminyltransferase 11 Mus musculus (Mouse) PR
Q8BGT9 Galnt12 Polypeptide N-acetylgalactosaminyltransferase 12 Mus musculus (Mouse) PR
Q8CF93 Galnt13 Polypeptide N-acetylgalactosaminyltransferase 13 Mus musculus (Mouse) PR
O08912 Galnt1 Polypeptide N-acetylgalactosaminyltransferase 1 Mus musculus (Mouse) PR
Q29121 GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 Sus scrofa (Pig) PR
Q925R7 Galnt10 Polypeptide N-acetylgalactosaminyltransferase 10 Rattus norvegicus (Rat) PR
O88422 Galnt5 Polypeptide N-acetylgalactosaminyltransferase 5 Rattus norvegicus (Rat) PR
Q6UE39 Galnt13 Polypeptide N-acetylgalactosaminyltransferase 13 Rattus norvegicus (Rat) PR
Q10473 Galnt1 Polypeptide N-acetylgalactosaminyltransferase 1 Rattus norvegicus (Rat) PR
Q7K755 gly-11 Putative polypeptide N-acetylgalactosaminyltransferase 11 Caenorhabditis elegans PR
P34678 gly-3 Polypeptide N-acetylgalactosaminyltransferase 3 Caenorhabditis elegans PR
10 20 30 40 50 60
MRKFAYCKVV LATSLIWVLL DMFLLLYFSE CNKCDEKKER GLPAGDVLEP VQKPHEGPGE
70 80 90 100 110 120
MGKPVVIPKE DQEKMKEMFK INQFNLMASE MIALNRSLPD VRLEGCKTKV YPDNLPTTSV
130 140 150 160 170 180
VIVFHNEAWS TLLRTVHSVI NRSPRHMIEE IVLVDDASER DFLKRPLESY VKKLKVPVHV
190 200 210 220 230 240
IRMEQRSGLI RARLKGAAVS KGQVITFLDA HCECTVGWLE PLLARIKHDR RTVVCPIIDV
250 260 270 280 290 300
ISDDTFEYMA GSDMTYGGFN WKLNFRWYPV PQREMDRRKG DRTLPVRTPT MAGGLFSIDR
310 320 330 340 350 360
DYFQEIGTYD AGMDIWGGEN LEISFRIWQC GGTLEIVTCS HVGHVFRKAT PYTFPGGTGQ
370 380 390 400 410 420
IINKNNRRLA EVWMDEFKNF FYIISPGVTK VDYGDISSRV GLRHKLQCKP FSWYLENIYP
430 440 450 460 470 480
DSQIPRHYFS LGEIRNVETN QCLDNMARKE NEKVGIFNCH GMGGNQVFSY TANKEIRTDD
490 500 510 520 530 540
LCLDVSKLNG PVTMLKCHHL KGNQLWEYDP VKLTLQHVNS NQCLDKATEE DSQVPSIRDC
550
NGSRSQQWLL RNVTLPEIF